ENDPAC model for defining a high-risk group for pancreatic cancer: Strengths, limitations and the way forward
Pancreatology · 2025-12 · 25 (8) · 1404-1406
DOI: 10.1016/j.pan.2025.11.007 ↗Kurz gefasst
Editorial in der Zeitschrift Pancreatology, 2025-12. Verfasst von Salman Khan und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, University of Texas Southwestern, Dallas, TX, USA; Department of Internal Medicine, West Virginia University School …. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 16 Literaturangaben. Gefördert von: Pancreatic Cancer Action Network.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Department of Internal Medicine, University of Texas Southwestern, Dallas, TX, USA; Department of Internal Medicine, West Virginia University School of Medicine, Morgantown, WV, USA.
- Department of Gastroenterology and Hepatology, University of Texas MD Anderson Cancer Center, USA. Electronic address: stchari@mdanderson.org.
Förderung
- Pancreatic Cancer Action Network
Zitieren
APA
Khan, S., & Chari, S. T. (2025). ENDPAC model for defining a high-risk group for pancreatic cancer: Strengths, limitations and the way forward. Pancreatology, 25(8), 1404-1406. https://doi.org/10.1016/j.pan.2025.11.007
Vancouver
Khan S, Chari ST. ENDPAC model for defining a high-risk group for pancreatic cancer: Strengths, limitations and the way forward. Pancreatology. 2025;25(8):1404-1406. doi:10.1016/j.pan.2025.11.007
BibTeX
@article{Khan2025,
author = {Khan, Salman and Chari, Suresh T},
title = {ENDPAC model for defining a high-risk group for pancreatic cancer: Strengths, limitations and the way forward},
journal = {Pancreatology},
year = {2025},
volume = {25},
number = {8},
pages = {1404--1406},
doi = {10.1016/j.pan.2025.11.007}
}
EUVIMED